Live Cell Imaging Market Report: Trends, Forecast and Competitive Analysis to 2030

Live Cell Imaging Trends and Forecast

The future of the global live cell imaging market looks promising with opportunities in the cell biology, stem cell, developmental biology, and drug discovery markets. The global live cell imaging market is expected to reach an estimated $5.87 billion by 2030 with a CAGR of 11.1% from 2024 to 2030. The major drivers for this market are increasing adoption of high-content screening techniques in drug discovery, growing incidence of cancer, and rising government funds for cell-based research.

A more than 150-page report is developed to help in your business decisions.

Live Cell Imaging by Segment

The study includes a forecast for the global live cell imaging by product & service, technology, application, end use, and region.

Live Cell Imaging Market by Product & Service [Shipment Analysis by Value from 2018 to 2030]:

• Instruments
• Consumables
• Software
• Services
• Others

Live Cell Imaging Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• Time-Lapse Microscopy
• Fluorescence Resonance Energy Transfer
• Fluorescence Recovery After Photobleaching
• High Content Screening
• Others

Live Cell Imaging Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Cell Biology
• Stem Cells
• Developmental Biology
• Drug Discovery
• Others

Live Cell Imaging Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Pharmaceutical & Biotechnology Companies
• Academic and Research Institutes
• Contract Research Organisations
• Others

Live Cell Imaging Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Live Cell Imaging Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies live cell imaging companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the live cell imaging companies profiled in this report include-

• Danaher
• Zeiss
• Nikon Corporation
• Olympus Corporation
• Perkinelmer
• Sartorius
• Agilent Technologies
• Thermo Fisher Scientific
• Etaluma
• Cytosmart Technologies

Live Cell Imaging Market Insights

Lucintel forecasts that instruments will remain the largest segment over the forecast period as it helps in providing critical insights into the fundamental nature of cellular and tissue function.

Within this market, stem cell will remain the largest segment due to its increasing adoption in cell replacement and tissue engineering therapies owing to their unique abilities to self-renew and differentiate into diverse cell types.

APAC is expected to witness highest growth over the forecast period due to growing investment in the healthcare infrastructure and research & development activities and increasing adoption of these imaging techniques in precision medicine and drug discovery applications.

Features of the Global Live Cell Imaging Market

Market Size Estimates: Live cell imaging market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Live cell imaging market by various segments, such as by product & service, technology, application, end use and region in terms of($B).

Regional Analysis: Live cell imaging market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product & services, technologies, applications, end uses, and regions for the live cell imaging market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the live cell imaging market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the live cell imaging market size?

Answer: The global live cell imaging market is expected to reach an estimated $5.87 billion by 2030.

Q.2 What is the growth forecast for live cell imaging market?

Answer: The global live cell imaging market is expected to grow with a CAGR of 11.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the live cell imaging market?

Answer: The major drivers for this market are increasing adoption of high-content screening techniques in drug discovery, growing incidence of cancer, and rising government funds for cell-based research.

Q4. What are the major segments for live cell imaging market?

Answer: The future of the live cell imaging market looks promising with opportunities in the cell biology, stem cell, developmental biology, and drug discovery markets.

Q5. Who are the key live cell imaging market companies?

Answer: Some of the key live cell imaging companies are as follows:

• Danaher
• ZEISS
• Nikon Corporation
• Olympus Corporation
• PerkinElmer
• Sartorius
• Agilent Technologies
• Thermo Fisher Scientific
• Etaluma
• CytoSMART Technologies

Q6. Which live cell imaging market segment will be the largest in future?

Answer: Lucintel forecasts that instruments will remain the largest segment over the forecast period as it helps in providing critical insights into the fundamental nature of cellular and tissue function.

Q7. In live cell imaging market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to growing investment in the healthcare infrastructure and research & development activities and increasing adoption of these imaging techniques in precision medicine and drug discovery applications.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the live cell imaging market by product & service (instruments, consumables, software, services, and others), technology (time-lapse microscopy, fluorescence resonance energy transfer, fluorescence recovery after photobleaching, high content screening, and others), application (cell biology, stem cells, developmental biology, drug discovery, and others), end use (pharmaceutical & biotechnology companies, academic and research institutes, contract research organisations, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?